𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Use of cytokeratin fragments 19.1 and 19.21 (Cyfra 21-1) in the differentiation of malignant and benign pleural effusions

✍ Scribed by Lee, Y. C. Gary ;Knox, B. S. ;Garrett, J. E.

Book ID
109001083
Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
428 KB
Volume
29
Category
Article
ISSN
0004-8291

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Release of cytokeratin-18 and -19 fragme
Release of cytokeratin-18 and -19 fragments (TPS and CYFRA 21-1) into the extracellular space during apoptosis
✍ Michael A. Sheard; Borek Vojtesek; Marta Simickova; Dalibor Valik πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 162 KB

## Abstract Serum fragments of cytokeratins‐18 and ‐19 (measured as TPS and CYFRA 21‐1, respectively) have traditionally been considered as markers of tumor proliferation, although the evidence is scarce for a causative relationship between proliferation and levels of TPS and CYFRA 21‐1. We examine

Diagnostic utility of pleural fluid carc
Diagnostic utility of pleural fluid carcinoembryonic antigen and CYFRA 21-1 in patients with pleural effusion: a systematic review and meta-analysis
✍ Ping Gu; Gang Huang; Yumei Chen; Cuiying Zhu; Jimin Yuan; Shile Sheng πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 260 KB

## Abstract Pleural effusions (PE) are the most common complications that may be produced by a wide variety of diseases. A large number of studies exploring the role of carcinoembryonic antigen (CEA) and cytokeratin fragment 19 (CYFRA 21‐1) marker in differential diagnosis of PE have been published